Neoadjuvant Treatment of Rectal Gastrointestinal Stromal Tumors with Imatinib

Abstract

Get full access to this article

View all access options for this article.

References

Eisenberg

B.L.

, Judson

Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.

Ann Surg Oncol 2004; 11: 465–75.

Hamada

, Ozaki

, Horimi

Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate.

Int J Clin Oncol 2008; 13: 355–60.

Eisenberg

B.L.

, Harris

, Blanke

C.D.

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

J Surg Oncol 2009; 99: 42–7.

Ebihara

, Okushiba

, Kawarada

Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: report of a case.

Surg Today 2008; 38: 174–7.